ENH almost proofread aim 1
This commit is contained in:
parent
240dbb7169
commit
4f51eca77c
|
@ -33,6 +33,5 @@
|
|||
MIP-1$\upalpha$ & 10 & 2\\
|
||||
MIP-1$\upbeta$ & 10 & 2\\
|
||||
RANTES & 10 & 2\\
|
||||
TGF$\upbeta$ & 1 & 3\\
|
||||
\hline
|
||||
\end{tabular}
|
|
@ -2660,6 +2660,19 @@ CONCLUSIONS: We developed a simplified, semi-closed system for the initial selec
|
|||
publisher = {Massachusetts Medical Society},
|
||||
}
|
||||
|
||||
@Article{Waysbort2013,
|
||||
author = {Nir Waysbort and Dor Russ and Benjamin M. Chain and Nir Friedman},
|
||||
journal = {The Journal of Immunology},
|
||||
title = {Coupled {IL}-2{\textendash}Dependent Extracellular Feedbacks Govern Two Distinct Consecutive Phases of {CD}4 T Cell Activation},
|
||||
year = {2013},
|
||||
month = {nov},
|
||||
number = {12},
|
||||
pages = {5822--5830},
|
||||
volume = {191},
|
||||
doi = {10.4049/jimmunol.1301575},
|
||||
publisher = {The American Association of Immunologists},
|
||||
}
|
||||
|
||||
@Comment{jabref-meta: databaseType:bibtex;}
|
||||
|
||||
@Comment{jabref-meta: grouping:
|
||||
|
|
587
tex/thesis.tex
587
tex/thesis.tex
|
@ -199,12 +199,14 @@
|
|||
\newacronym{zfn}{ZFN}{zinc-finger nuclease}
|
||||
\newacronym{talen}{TALEN}{transcription activator-like effector nuclease}
|
||||
\newacronym{qbd}{QbD}{quality-by-design}
|
||||
\newacronym{aws}{AWS}{amazon web services}
|
||||
\newacronym{aws}{AWS}{Amazon Web Services}
|
||||
\newacronym{qpcr}{qPCR}{quantitative polymerase chain reaction}
|
||||
\newacronym{cstr}{CSTR}{continuously stirred tank bioreactor}
|
||||
\newacronym{esc}{ESC}{embryonic stem cell}
|
||||
\newacronym{msc}{MSC}{mesenchymal stromal cells}
|
||||
\newacronym{scfv}{scFv}{single-chain fragment variable}
|
||||
\newacronym{hepes}{HEPES}{4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid}
|
||||
\newacronym{nhs}{NHS}{N-hydroxysulfosuccinimide}
|
||||
|
||||
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|
||||
% SI units for uber nerds
|
||||
|
@ -289,6 +291,7 @@
|
|||
\newcommand{\catnum}[2]{(#1, #2)}
|
||||
\newcommand{\product}[3]{#1 \catnum{#2}{#3}}
|
||||
\newcommand{\thermo}{Thermo Fisher}
|
||||
\newcommand{\gehc}{GE Healthcare}
|
||||
\newcommand{\sigald}{Sigma Aldrich}
|
||||
\newcommand{\miltenyi}{Miltenyi Biotech}
|
||||
\newcommand{\bl}{Biolegend}
|
||||
|
@ -1266,23 +1269,9 @@ microcarriers functionalized with \acd{3} and \acd{28} \glspl{mab} will
|
|||
provide superior expansion and memory phenotype compared to state-of-the-art
|
||||
bead-based T cell expansion technology.
|
||||
|
||||
% TODO this doesn't flow that well and is repetitive with what comes above
|
||||
|
||||
Microcarriers have been used throughout the bioprocess industry for adherent
|
||||
cell cultures such as \gls{cho} cells and stem cells, as they are able to
|
||||
achieve much greater surface area per unit volume than traditional 2D
|
||||
cultures\cite{Heathman2015, Sart2011}. Adding adhesive \glspl{mab} to the
|
||||
microcarriers will adapt them for suspension cell cultures such as T cells.
|
||||
Consequently, the large macroporous structure will allow T cells to cluster more
|
||||
closely, which in turn will enable better autocrine and paracrine signaling.
|
||||
Specifically, two cytokines that are secreted by T cells, IL-2 and IL-15, are
|
||||
known to drive expansion and memory phenotype respectively\cite{Buck2016}.
|
||||
Therefore, the proposed microcarrier system should enable greater expansion and
|
||||
better retention of memory phenotype compared to current bead-based methods.
|
||||
|
||||
\section{methods}
|
||||
|
||||
\subsection{dms functionalization}\label{sec:dms_fab}
|
||||
\subsection{DMS functionalization}\label{sec:dms_fab}
|
||||
|
||||
\begin{figure*}[ht!]
|
||||
\begingroup
|
||||
|
@ -1294,24 +1283,23 @@ better retention of memory phenotype compared to current bead-based methods.
|
|||
\label{fig:dms_flowchart}
|
||||
\end{figure*}
|
||||
|
||||
Gelatin microcarriers (\gls{cus} or \gls{cug}, GE Healthcare, DG-2001-OO and
|
||||
DG-0001-OO) were suspended at \SI{20}{\mg\per\ml} in 1X \gls{pbs} and
|
||||
autoclaved. All subsequent steps were done aseptically, and all reactions were
|
||||
carried out at \SI{20}{\mg\per\ml} carriers at room temperature and agitated
|
||||
using an orbital shaker with a \SI{3}{\mm} orbit diameter. After autoclaving,
|
||||
the microcarriers were washed using sterile \gls{pbs} three times in a 10:1
|
||||
volume ratio. \product{\Gls{snb}}{\thermo}{21217} was dissolved at
|
||||
approximately \SI{10}{\uM} in sterile ultrapure water, and the true
|
||||
concentration was then determined using the \gls{haba} assay (see below).
|
||||
\SI{5}{\ul\of{\ab}\per\mL} \gls{pbs} was added to carrier suspension and allowed
|
||||
to react for \SI{60}{\minute} at \SI{700}{\rpm} of agitation. After the
|
||||
reaction, the amount of biotin remaining in solution was quantified using the
|
||||
\gls{haba} assay (see below). The carriers were then washed three times, which
|
||||
entailed adding sterile \gls{pbs} in a 10:1 volumetric ratio, agitating at
|
||||
\SI{900}{\rpm} for \SI{10}{\minute}, adding up to a 15:1 volumetric ratio
|
||||
(relative to reaction volume) of sterile \gls{pbs}, centrifuging at
|
||||
\SI{1000}{\gforce} for \SI{1}{\minute}, and removing all liquid back down to the
|
||||
reaction volume.
|
||||
\product{\gls{cus}}{\gehc}{DG-2001-OO} or \product{\gls{cug}}{\gehc}{DG-0001-OO}
|
||||
were suspended at \SI{20}{\mg\per\ml} in 1X \gls{pbs} and autoclaved. All
|
||||
subsequent steps were done aseptically, and all reactions were carried out at
|
||||
\SI{20}{\mg\per\ml} carriers at room temperature and agitated using an orbital
|
||||
shaker with a \SI{3}{\mm} orbit diameter. After autoclaving, the microcarriers
|
||||
were washed using sterile \gls{pbs} three times in a 10:1 volume ratio.
|
||||
\product{\Gls{snb}}{\thermo}{21217} was dissolved at approximately \SI{10}{\uM}
|
||||
in sterile ultrapure water, and the true concentration was then determined using
|
||||
the \gls{haba} assay (see below). \SI{5}{\ul\of{\ab}\per\mL} \gls{pbs} was added
|
||||
to carrier suspension and allowed to react for \SI{60}{\minute} at
|
||||
\SI{700}{\rpm} of agitation. After the reaction, the amount of biotin remaining
|
||||
in solution was quantified using the \gls{haba} assay (see below). The carriers
|
||||
were then washed three times, which entailed adding sterile \gls{pbs} in a 10:1
|
||||
volumetric ratio, agitating at \SI{900}{\rpm} for \SI{10}{\minute}, adding up to
|
||||
a 15:1 volumetric ratio (relative to reaction volume) of sterile \gls{pbs},
|
||||
centrifuging at \SI{1000}{\gforce} for \SI{1}{\minute}, and removing all liquid
|
||||
back down to the reaction volume.
|
||||
|
||||
To coat with \gls{stp}, \SI{40}{\ug\per\mL} \product{\gls{stp}}{Jackson
|
||||
Immunoresearch}{016-000-114} was added and allowed to react for
|
||||
|
@ -1332,13 +1320,19 @@ sampled to quantify remaining \gls{mab} concentration using an
|
|||
step to remove excess \gls{stp}. They were washed once again in the cell culture
|
||||
media to be used for the T cell expansion.
|
||||
|
||||
\begin{table}[!h] \centering
|
||||
\caption{Properties of the microcarriers used}
|
||||
\label{tab:carrier_props}
|
||||
\input{../tables/carrier_properties.tex}
|
||||
\end{table}
|
||||
|
||||
The concentration of the final \gls{dms} suspension was found by taking a
|
||||
\SI{50}{\uL} sample, plating in a well, and imaging the entire well. The image
|
||||
was then manually counted to obtain a concentration. Surface area for
|
||||
\si{\ab\per\um\squared} was calculated using the properties for \gls{cus} and
|
||||
\gls{cug} as given by the manufacturer {Table X}.
|
||||
\gls{cug} as given by the manufacturer \cref{tab:carrier_props}.
|
||||
|
||||
\subsection{dms quality control assays}
|
||||
\subsection{DMS quality control assays}
|
||||
|
||||
Biotin was quantified using the \product{\gls{haba} assay}{\sigald}{H2153-1VL}.
|
||||
In the case of quantifying \gls{snb} prior to adding it to the microcarriers,
|
||||
|
@ -1350,15 +1344,15 @@ Spectrophotometer using \product{\SI{70}{\ul} cuvettes}{BrandTech}{759200}. The
|
|||
extinction coefficient at \SI{500}{\nm} for \gls{haba}/avidin was assumed to be
|
||||
\SI{34000}{\per\cm\per\molar}.
|
||||
|
||||
\gls{stp} binding to the carriers was quantified indirectly using a
|
||||
The \gls{stp} binding to the microcarriers was quantified indirectly using a
|
||||
\product{\gls{bca} kit}{\thermo}{23227} according to the manufacturer’s
|
||||
instructions, with the exception that the standard curve was made with known
|
||||
concentrations of purified \gls{stp} instead of \gls{bsa}. Absorbance at
|
||||
\SI{592}{\nm} was quantified using a Biotek plate reader.
|
||||
\SI{592}{\nm} was quantified using a BioTek plate reader.
|
||||
|
||||
\Gls{mab} binding to the microcarriers was quantified indirectly using an
|
||||
The \gls{mab} binding to the microcarriers was quantified indirectly using an
|
||||
\gls{elisa} assay per the manufacturer’s instructions, with the exception that
|
||||
the same antibodies used to coat the carriers were used as the standard for the
|
||||
the same \glspl{mab} used to coat the carriers were used as the standard for the
|
||||
\gls{elisa} standard curve.
|
||||
|
||||
Open biotin binding sites on the \glspl{dms} after \gls{stp} coating was
|
||||
|
@ -1366,18 +1360,18 @@ quantified indirectly using \product{\gls{fitcbt}}{\thermo}{B10570}.
|
|||
Briefly, \SI{400}{\pmol\per\ml} \gls{fitcbt} were added to \gls{stp}-coated
|
||||
carriers and allowed to react for \SI{20}{\minute} at room temperature under
|
||||
constant agitation. The supernatant was quantified against a standard curve of
|
||||
\gls{fitcbt} using a Biotek plate reader.
|
||||
\gls{fitcbt} using a BioTek plate reader.
|
||||
|
||||
\Gls{stp} binding was verified after the \gls{stp}-binding step visually by
|
||||
adding \gls{fitcbt} to the \gls{stp}-coated \glspl{dms}, resuspending in
|
||||
\SI{1}{\percent} agarose gel, and imaging on a \product{lightsheet
|
||||
microscope}{Zeiss}{Z.1}. \Gls{mab} binding was verified visually by first
|
||||
staining with \product{\anti{\gls{igg}}-\gls{fitc}}{\bl}{406001}, incubating for
|
||||
\SI{30}{\minute}, washing with \gls{pbs}, and imaging on a confocal microscope.
|
||||
microscope}{Zeiss}{Z.1}. Overall \gls{mab} binding was verified visually
|
||||
by first staining with \product{\anti{\gls{igg}}-\gls{fitc}}{\bl}{406001},
|
||||
incubating for \SI{30}{\minute}, washing with \gls{pbs}, and imaging on a
|
||||
confocal microscope.
|
||||
|
||||
\subsection{t cell culture}\label{sec:tcellculture}
|
||||
|
||||
% TODO verify countess product number
|
||||
Cryopreserved primary human T cells were either obtained as sorted
|
||||
\product{\cdp{3} T cells}{Astarte Biotech}{1017} or isolated from
|
||||
\product{\glspl{pbmc}}{Zenbio}{SER-PBMC} using a negative selection
|
||||
|
@ -1390,15 +1384,15 @@ otherwise noted. Initial cell density was \SIrange{2e6}{2.5e6}{\cell\per\ml} to
|
|||
in a 96 well plate with \SI{300}{\ul} volume. Serum-free media was either
|
||||
\product{OpTmizer}{\thermo}{A1048501} or
|
||||
\product{TexMACS}{\miltenyi}{170-076-307} supplemented with
|
||||
\SIrange{100}{400}{\IU\per\ml} \product{\gls{rhil2}}{Peprotech}{200-02}. Cell
|
||||
cultures were expanded for \SI{14}{\day} as counted from the time of initial
|
||||
seeding and activation. Cell counts and viability were assessed using
|
||||
\product{trypan blue}{\thermo}{T10282} or \product{\gls{aopi}}{Nexcelom
|
||||
Bioscience}{CS2-0106-5} and a \product{Countess Automated Cell Counter}{Thermo
|
||||
Fisher}{Countess 3 FL}. Media was added to cultures every \SIrange{2}{3}{\day}
|
||||
depending on media color or a \SI{300}{\mg\per\deci\liter} minimum glucose
|
||||
threshold. Media glucose was measured using a \product{GlucCell glucose
|
||||
meter}{Chemglass}{CLS-1322-02}.
|
||||
\SIrange{100}{400}{\IU\per\ml} \product{\gls{rhil2}}{Peprotech}{200-02} unless
|
||||
otherwise noted. Cell cultures were expanded for \SI{14}{\day} as counted from
|
||||
the time of initial seeding and activation. Cell counts and viability were
|
||||
assessed using \product{trypan blue}{\thermo}{T10282} or
|
||||
\product{\gls{aopi}}{Nexcelom Bioscience}{CS2-0106-5} and a \product{Countess
|
||||
Automated Cell Counter}{Thermo Fisher}{Countess 3 FL}. Media was added to
|
||||
cultures every \SIrange{2}{3}{\day} depending on media color or a
|
||||
\SI{300}{\mg\per\deci\liter} minimum glucose threshold. Media glucose was
|
||||
measured using a \product{GlucCell glucose meter}{Chemglass}{CLS-1322-02}.
|
||||
|
||||
Cells on the \glspl{dms} were visualized by adding \SI{0.5}{\ul}
|
||||
\product{\gls{stppe}}{\bl}{405204} and \SI{2}{ul}
|
||||
|
@ -1406,19 +1400,20 @@ Cells on the \glspl{dms} were visualized by adding \SI{0.5}{\ul}
|
|||
imaging on a spinning disk confocal microscope.
|
||||
|
||||
In the case of Grex bioreactors, we either used a \product{24 well plate}{Wilson
|
||||
Wolf}{P/N 80192M} or a \product{6 well plate}{P/N 80240M}.
|
||||
Wolf}{P/N 80192M} or a \product{6 well plate}{Wilson Wolf}{P/N 80240M}.
|
||||
|
||||
\subsection{Quantifying cells on DMS interior}
|
||||
|
||||
% TODO add a product number to MTT (if I can find it)
|
||||
Cells were stained and visualized using \gls{mtt}. \glspl{dms} with attached and
|
||||
loosely attached cells were sampled as desired and filtered through a
|
||||
\SI{40}{\um} cell strainer. While still in the cell strainer, \glspl{dms} were
|
||||
washed twice with \gls{pbs} and then dried by pulling liquid through the bottom
|
||||
of the cell strainer via a micropipette and dabbing with a KimWipe. \glspl{dms}
|
||||
were transferred to a 24 well plate with \SI{400}{\ul} media. \SI{40}{\ul}
|
||||
\gls{mtt} was added to each well and allowed to incubate for \SI{3}{\hour},
|
||||
after which \glspl{dms} with cell were visualized via a brightfield microscope.
|
||||
To visualize T cells on the interior of the \glspl{dms}, we stained them with
|
||||
\gls{mtt}. \glspl{dms} with attached and loosely attached cells were sampled as
|
||||
desired and filtered through a \SI{40}{\um} cell strainer. While still in the
|
||||
cell strainer, \glspl{dms} were washed twice with \gls{pbs} and then dried by
|
||||
pulling liquid through the bottom of the cell strainer via a micropipette and
|
||||
dabbing with a KimWipe. \glspl{dms} were transferred to a 24 well plate with
|
||||
\SI{400}{\ul} media. \SI{40}{\ul} \gls{mtt} was added to each well and allowed
|
||||
to incubate for \SI{3}{\hour}, after which \glspl{dms} with cell were visualized
|
||||
via a brightfield microscope.
|
||||
|
||||
To quantify cells on the interior of \glspl{dms}, cells and \glspl{dms} were
|
||||
isolated analogously to those for the \gls{mtt} stain up until the drying step.
|
||||
|
@ -1433,13 +1428,13 @@ Apoptosis was quantified using \gls{anv} according to the manufacturer's
|
|||
instructions. Briefly, cells were transferred to flow tubes and washed twice
|
||||
with \gls{pbs} by adding \SI{3}{\ml} to each tube, centrifuging for
|
||||
\SI{400}{\gforce}, and aspirating the liquid down to \SI{200}{\ul}. The cells
|
||||
were analogously washed a third time with staining buffer (\SI{10}{\mM} HEPES,
|
||||
\SI{140}{\mM} NaCl, \SI{2.5}{\mM} CaCl\textsubscript{2}) and aspirated down to a
|
||||
final volume of \SI{100}{\ul}. Cells were stained in this volume with
|
||||
were analogously washed a third time with staining buffer (\SI{10}{\mM}
|
||||
\gls{hepes}, \SI{140}{\mM} NaCl, \SI{2.5}{\mM} \ce{CaCl2}) and aspirated down to
|
||||
a final volume of \SI{100}{\ul}. Cells were stained in this volume with
|
||||
\SI{1}{\ul} \product{\gls{anv}-\gls{fitc}}{\bl}{640906} and \SI{5}{\ul}
|
||||
\product{\gls{pi}}{\thermo}{P3566} and incubated for \SI{15}{\minute} at gls{rt}
|
||||
in the dark. After incubation, \SI{400}{\ul} staining buffer was added to each
|
||||
tube. Each tube was then analyzed via flow cytometry.
|
||||
\product{\gls{pi}}{\thermo}{P3566} and incubated for \SI{15}{\minute} at
|
||||
\gls{rt} in the dark. After incubation, \SI{400}{\ul} staining buffer was added
|
||||
to each tube. Each tube was then analyzed via flow cytometry.
|
||||
|
||||
\subsection{quantification of Caspase-3/7}
|
||||
|
||||
|
@ -1453,13 +1448,13 @@ After incubation, cells were immediately analyzed via flow cytometry.
|
|||
|
||||
\Gls{bcl2} was quantified using an \product{Human Total Bcl-2 DuoSet \gls{elisa}
|
||||
kit}{Rnd Systems}{DYC827B-2} according to the manufacturer's instructions and
|
||||
supplemented with \product{5X diluent buffer}{\bl}{421203}, \product{\gls{tmb}
|
||||
substrate solution}{eBioscience}{00-4201-56}, and \SI{2}{\normal}
|
||||
H\textsubscript{2}SO\textsubscript{4} stop solution made in house. Briefly,
|
||||
cells were lysed using \product{10X lysis buffer}{Cell Signaling}{9803S}, and
|
||||
the lysate was quantified for protein using a \product{\gls{bca}
|
||||
assay}{\thermo}{23225} as directed. Standardized lysates were measured using
|
||||
the \gls{elisa} kit as directed.
|
||||
supplemented with \product{\gls{tmb} substrate
|
||||
solution}{eBioscience}{00-4201-56}, \product{5X diluent buffer}{\bl}{421203},
|
||||
and \SI{2}{\normal} \ce{H2SO4} stop solution made in house. Briefly, cells were
|
||||
lysed using \product{10X lysis buffer}{Cell Signaling}{9803S}, and the lysate
|
||||
was quantified for protein using a \product{\gls{bca} assay}{\thermo}{23225} as
|
||||
directed. Standardized lysates were measured using the \gls{elisa} kit as
|
||||
directed.
|
||||
|
||||
\subsection{chemotaxis assay}
|
||||
|
||||
|
@ -1479,24 +1474,30 @@ transwell was quantified for total cells using \product{countbright
|
|||
Cytotoxicity of expanded \gls{car} T cells was assessed using a degranulation
|
||||
assay as previously described\cite{Schmoldt1975}. Briefly, \num{3e5} T cells
|
||||
were incubated with \num{1.5e5} target cells consisting of either \product{K562
|
||||
wild type cells}{ATCC}{CCL-243} or CD19- expressing K562 cells transformed
|
||||
wild type cells}{ATCC}{CCL-243} or CD19- expressing K562 cells transformed
|
||||
with \gls{crispr} (kindly provided by Dr.\ Yvonne Chen, UCLA)\cite{Zah2016}.
|
||||
Cells were seeded in a flat bottom 96 well plate with \SI{1}{\ug\per\ml}
|
||||
\product{\acd{49d}}{eBioscience}{16-0499-81}, \SI{2}{\micro\molar} \product{monensin}{eBioscience}{
|
||||
00-4505-51}, and \SI{1}{\ug\per\ml} \product{\acd{28}}{eBioscience}{302914} (all
|
||||
functional grade \glspl{mab}) with \SI{250}{\ul} total volume. After
|
||||
\SI{4}{\hour} incubation at \SI{37}{\degreeCelsius}, cells were stained for CD3,
|
||||
CD4, and CD107a and analyzed on a BD LSR Fortessa. Readout was calculated as the
|
||||
percent \cdp{107a} cells of the total \cdp{8} fraction.
|
||||
\product{\acd{49d}}{eBioscience}{16-0499-81}, \SI{2}{\micro\molar}
|
||||
\product{monensin}{eBioscience}{ 00-4505-51}, and \SI{1}{\ug\per\ml}
|
||||
\product{\acd{28}}{eBioscience}{302914} (all functional grade \glspl{mab}) with
|
||||
\SI{250}{\ul} total volume. After \SI{4}{\hour} incubation at
|
||||
\SI{37}{\degreeCelsius}, cells were stained for CD3, CD4, and CD107a and
|
||||
analyzed on a \bd{} LSR Fortessa. Readout was calculated as the percent
|
||||
\cdp{107a} cells of the total \cdp{8} fraction.
|
||||
|
||||
\subsection{car expression}
|
||||
\subsection{CAR expression}
|
||||
|
||||
\gls{car} expression was quantified as previously described\cite{Zheng2012}.
|
||||
Briefly, cells were washed once and stained with \product{biotinylated
|
||||
\gls{ptnl}}{\thermo}{29997}. After a subsequent wash, cells were stained with
|
||||
\product{\gls{pe}-\gls{stp}}{\bl}{405204}, washed again, and analyzed on a
|
||||
BD Accuri. Readout was percent \gls{pe}+ cells as compared to secondary controls
|
||||
(\gls{pe}-\gls{stp} with no \gls{ptnl}).
|
||||
\gls{car} expression of the \anti{CD19} \gls{car} was quantified as previously
|
||||
described\cite{Zheng2012}. Briefly, cells were washed once and stained with
|
||||
\product{biotinylated \gls{ptnl}}{\thermo}{29997}. After a subsequent wash,
|
||||
cells were stained with \product{\gls{pe}-\gls{stp}}{\bl}{405204}, washed again,
|
||||
and analyzed on a \bd{} Accuri. Readout was percent \gls{pe}+ cells as compared
|
||||
to secondary controls (\gls{pe}-\gls{stp} with no \gls{ptnl}).
|
||||
|
||||
\gls{car} expression of the \anti{\gls{bcma}} \gls{car} was quantified using a
|
||||
\product{\gls{fitc}-labeled \gls{bcma} protein}{Acro}{Bca-hf254}. \SI{100}{\ng}
|
||||
was added to tubes analogously to \gls{ptnl} and incubated for \SI{45}{\minute}
|
||||
prior to analyzing on a \bd{} Accuri
|
||||
|
||||
\subsection{car plasmid and lentiviral transduction}
|
||||
|
||||
|
@ -1527,39 +1528,37 @@ Kochenderfer at the NIH)\cite{Lam2020} was added to \SI{50}{\ul}
|
|||
\product{DH5$\upalpha$ cells}{\thermo}{18265017} and incubated for
|
||||
\SI{30}{\minute} on ice. The cell mixture was then heat-shocked at
|
||||
\SI{42}{\degreeCelsius} for \SI{20}{\minute} before being placed on ice for
|
||||
another \SI{2}{\minute}. \SI{950}{\ul} \product{LB Broth}{TODO}{TODO} was added
|
||||
to the cells which were then centrifuged for \SI{1}{\hour} at \SI{225}{\rpm}.
|
||||
\SI{20}{\ul} of the cell mixture was then spread over selection plates and
|
||||
incubated overnight at \SI{37}{\degreeCelsius}. Colonies were selected the
|
||||
following day and incubated in \product{LB Broth}{TODO}{TODO} with
|
||||
\product{ampicillin}{\sigald{}}{A9518-5G} at \SI{37}{\degreeCelsius} for
|
||||
\SIrange{12}{16}{\hour} prior to using the \product{miniprep kit}{Qiagen}{27104}
|
||||
as per the manufacturer's instructions to isolate the plasmid DNA. Transfer
|
||||
plasmid along with \product{pMDLg/pRRE}{Addgene}{12251},
|
||||
\product{pRSV-Rev}{Addgene}{12253}, and \product{pMD2.G}{Addgene}{12259}
|
||||
(generously provided by the Sloan lab at Emory University) in
|
||||
\product{Opti-Mem}{\thermo}{31-985-070} with \product{lipfectamine
|
||||
2000}{\thermo}{11668019} were added dropwise to HEK 293T cells and incubated
|
||||
for \SI{6}{\hour}, after which all media was replaced with fresh fresh media.
|
||||
After \SI{24}{\hour} and \SI{48}{\hour}, supernatent was collected, pooled, and
|
||||
concentrated using a \product{Lenti-X concentrator}{Takara}{631231} prior to
|
||||
storing at \SI{-80}{\degreeCelsius}.
|
||||
another \SI{2}{\minute}. \SI{950}{\ul} luria broth was added to the cells which
|
||||
were then centrifuged for \SI{1}{\hour} at \SI{225}{\rpm}. \SI{20}{\ul} of the
|
||||
cell mixture was then spread over selection plates and incubated overnight at
|
||||
\SI{37}{\degreeCelsius}. Colonies were selected the following day and incubated
|
||||
in luria broth with \product{ampicillin}{\sigald{}}{A9518-5G} at
|
||||
\SI{37}{\degreeCelsius} for \SIrange{12}{16}{\hour} prior to using the
|
||||
\product{miniprep kit}{Qiagen}{27104} as per the manufacturer's instructions to
|
||||
isolate the plasmid DNA. Transfer plasmid along with
|
||||
\product{pMDLg/pRRE}{Addgene}{12251}, \product{pRSV-Rev}{Addgene}{12253}, and
|
||||
\product{pMD2.G}{Addgene}{12259} (generously provided by the Sloan lab at Emory
|
||||
University) in \product{Opti-Mem}{\thermo}{31-985-070} with
|
||||
\product{lipfectamine 2000}{\thermo}{11668019} were added dropwise to HEK 293T
|
||||
cells and incubated for \SI{6}{\hour}, after which all media was replaced with
|
||||
fresh fresh media. After \SI{24}{\hour} and \SI{48}{\hour}, supernatent was
|
||||
collected, pooled, and concentrated using a \product{Lenti-X
|
||||
concentrator}{Takara}{631231} prior to storing at \SI{-80}{\degreeCelsius}.
|
||||
|
||||
\subsection{sulfo-NHS-biotin hydrolysis quantification}
|
||||
|
||||
The equation for hydrolysis of \gls{snb} was assumed to follow
|
||||
The equation for hydrolysis of \gls{snb} to biotin and \gls{nhs} is given by
|
||||
\cref{chem:snb_hydrolysis}.
|
||||
|
||||
% TODO make this look prettier
|
||||
\begin{equation}
|
||||
\label{chem:snb_hydrolysis}
|
||||
\ce{NHS-CO-Biotin + OH- -> NHS- + Biotin-COOH}
|
||||
\end{equation}
|
||||
|
||||
The hydrolysis of \gls{snb} was performed spectroscopically. \gls{snb} was added
|
||||
to either \gls{di} water or \gls{pbs} in a UV-transparent 96 well plate. Kinetic
|
||||
analysis using a Biotech Plate Reader began immediately after prep, and readings
|
||||
at \SI{260}{\nm} were taken every minute for \SI{2}{\hour}.
|
||||
Measuring the hydrolysis of \gls{snb} was performed spectroscopically. \gls{snb}
|
||||
was added to either \gls{di} water or \gls{pbs} in a UV-transparent 96 well
|
||||
plate. Kinetic analysis using a BioTek plate reader began immediately after
|
||||
prep, and readings at \SI{260}{\nm} were taken every minute for \SI{2}{\hour}.
|
||||
|
||||
\subsection{reaction kinetics quantification}
|
||||
|
||||
|
@ -1568,41 +1567,44 @@ experimentally. \SI{40}{\ug\per\ml} \gls{stp} was added to multiple batches of
|
|||
biotin-coated microcarriers, and supernatents were taken at fixed intervals and
|
||||
quantified for \gls{stp} protein using the \gls{bca} assay.
|
||||
|
||||
% TODO defend why the microcarriers were saturated with stp
|
||||
The effective diffusivity of the microcarriers was determined using a
|
||||
The geometric diffusivity of the microcarriers was determined using a
|
||||
pseudo-steady-state model. Each microcarrier was assumed to be a porous sphere
|
||||
with a fixed number of `\gls{stp} binding sites' equal to the number of
|
||||
\gls{stp} molecules experimentally determined to bind to the microcarriers.
|
||||
Because the reaction rate between biotin and \gls{stp} was so fast, we assumed
|
||||
that the interface of free biotin shrunk as a function of \gls{stp} bound until
|
||||
the center of the microcarriers was reached. We also assumed that the pores in
|
||||
the microcarriers were large enough that the interactions between the \gls{stp}
|
||||
and surfaces would be small, thus the apparent diffusivity could be represented
|
||||
as a fraction of the diffusion coefficient of \gls{stp} in water. This model was
|
||||
given by \cref{eqn:stp_diffusion_1,eqn:stp_diffusion_2}:
|
||||
with a fixed number of uniformly distributed `\gls{stp} binding sites' equal to
|
||||
the number of \gls{stp} molecules experimentally determined to bind to the
|
||||
microcarriers. Because the reaction rate between biotin and \gls{stp} is so fast
|
||||
(it is the strongest non-covalent bond in known existence), we assumed that the
|
||||
interface of free biotin shrunk as a function of \gls{stp} diffusing to the
|
||||
unbound biotin interface until the center of the microcarriers was reached. We
|
||||
also assumed that the pores in the microcarriers were large enough that the
|
||||
interactions between the \gls{stp} and surfaces would be small, thus the
|
||||
geometric diffusivity could be represented as a fraction of the diffusion
|
||||
coefficient of \gls{stp} in water. This model was given by
|
||||
\cref{eqn:stp_diffusion_1,eqn:stp_diffusion_2}:
|
||||
|
||||
% TODO actually derive these equations, eg state the initial conditions and
|
||||
% governing equation
|
||||
\begin{equation}
|
||||
\label{eqn:stp_diffusion_1}
|
||||
\frac{dr}{dt} = \frac{-D_{app}C}{Br(1-r/R)}
|
||||
\frac{dr}{dt} = \frac{-D_{app}C_b}{Br(1-r/R)}
|
||||
\end{equation}
|
||||
|
||||
\begin{equation}
|
||||
\label{eqn:stp_diffusion_2}
|
||||
\frac{dC}{dt} = \frac{-4 \pi n D_{app} C}{V(1/r-1/R)}
|
||||
\frac{dC_b}{dt} = \frac{-4 \pi n D_{app} C_b}{V(1/r-1/R)}
|
||||
\end{equation}
|
||||
|
||||
\noindent where
|
||||
\begin{itemize}[label={}]
|
||||
\item $D_{app}$ is the apparent diffusion rate which is equal to $D_{STP}\beta$
|
||||
\item $D_{STP}$ the diffusion rate of \gls{stp} (or \glspl{mab} for later
|
||||
calculations) in water
|
||||
\item $D_{app}$ is the apparent diffusion rate of species $X$ which is equal to
|
||||
$D\beta$
|
||||
\item $D$ the diffusion rate of species $X$ in water at room temperature
|
||||
(where $X$ is \gls{stp} in this example and \glspl{mab} later in this section)
|
||||
\item $\beta$ a fractional parameter representing the tortuousity and void
|
||||
fraction of the microcarriers (here called the `geometric diffusivity')
|
||||
\item $r$ is the interfatial radius of the unbound biotin within a microcarrier
|
||||
\item $r$ is the interfatial radius of the unbound binding sites for species $X$
|
||||
within a microcarrier
|
||||
\item $t$ is the reaction time
|
||||
\item $C$ is the concentration of \gls{stp} in the bulk solution
|
||||
\item $C_b$ is the concentration of species $X$ in the bulk solution
|
||||
\item $V$ is the volume of the bulk medium
|
||||
\item $R$ is the average radius of the microcarriers
|
||||
\item $n$ is the number of microcarriers in the reaction volume
|
||||
|
@ -1646,17 +1648,15 @@ partial differential equation and boundary conditions:
|
|||
\noindent where (in addition to the variables given already for
|
||||
\cref{eqn:stp_diffusion_1,eqn:stp_diffusion_2})
|
||||
\begin{itemize}[label={}]
|
||||
\item $N_i$ is the radial flux of the species in question inside the
|
||||
microcarriers
|
||||
\item $C_i$ is the concentration of the species in question inside the
|
||||
microcarriers
|
||||
\item $C_{i,0}$ is the initial concentration of the species in question inside
|
||||
\item $N_i$ is the radial flux of species $X$ inside the microcarriers
|
||||
\item $C_i$ is the concentration of species $X$ inside the microcarriers
|
||||
\item $C_{i,0}$ is the initial concentration of species $X$ inside
|
||||
the microcarriers (which is assumed to be the concentration in the bulk before
|
||||
the wash volume is added)
|
||||
\item $C_{b,0}$ is the initial bulk concentration of the species in question
|
||||
outside the microcarriers after the initial wash volume has been added
|
||||
\item $C_{b,\infty}$ is the final bulk concentration of the species in
|
||||
question outside the microcarriers
|
||||
\item $C_{b,0}$ is the initial bulk concentration of species $X$ outside the
|
||||
microcarriers after the initial wash volume has been added
|
||||
\item $C_{b,\infty}$ is the final bulk concentration of species $X$ outside the
|
||||
microcarriers
|
||||
\end{itemize}
|
||||
|
||||
Note that in order to avoid solving a moving boundary value problem, the
|
||||
|
@ -1669,7 +1669,7 @@ concentration should change little.
|
|||
The same diffusion coefficients were used in determining the kinetics of the
|
||||
washing steps, and \SI{5.0e-6}{\cm\squared\per\second}\cite{Niether2020} was
|
||||
used as the diffusion coefficient for free biotin (which should be the only
|
||||
species left in solution after all the \gls{snb} has hydrolyzed).
|
||||
reactive species left in solution after all the \gls{snb} has hydrolyzed).
|
||||
|
||||
All diffusion coefficients were taken to be valid at \gls{rt} and in \gls{di}
|
||||
water, which is a safe assumption given that our reaction medium was 1X
|
||||
|
@ -1689,17 +1689,17 @@ thawed at \gls{rt} and vortexed to ensure homogeneity. To run the plate,
|
|||
\SI{25}{\ul} of magnetic beads were added to the plate and washed 3X using
|
||||
\SI{300}{\ul} of wash buffer. \SI{25}{\ul} of samples or standard were added to
|
||||
the plate and incubated for \SI{120}{\minute} at \SI{850}{\rpm} at \gls{rt}
|
||||
before washing analogously 3X with wash. \SI{12.5}{\ul} detection \glspl{mab}
|
||||
and \SI{25}{\ul} \gls{stppe} were sequentially added, incubated for
|
||||
before washing analogously 3X with wash buffer. \SI{12.5}{\ul} detection
|
||||
\glspl{mab} and \SI{25}{\ul} \gls{stppe} were sequentially added, incubated for
|
||||
\SI{30}{\minute} and vortexed, and washed analogously to the sample step.
|
||||
Finally, samples were resuspended in \SI{120}{\ul} reading buffer and analyzed
|
||||
via a BioRad Bioplex 200 plate reader. An 8 point log2 standard curve was used,
|
||||
and all samples were run with single replicates.
|
||||
via a BioRad Bioplex 200 plate reader. An 8 point log\textsubscript{2} standard
|
||||
curve was used, and all samples were run with single replicates.
|
||||
|
||||
Luminex data was preprocessed using R for inclusion in downstream analysis as
|
||||
follows. Any cytokine level that was over-range (`OOR >' in output spreadsheet)
|
||||
was set to the maximum value of the standard curve for that cytokine. Any value
|
||||
that was under-range (`OOR <l in output spreadsheet) was set to zero. All values
|
||||
that was under-range (`OOR <' in output spreadsheet) was set to zero. All values
|
||||
that were extrapolated from the standard curve were left unchanged.
|
||||
|
||||
\begin{table}[!h] \centering
|
||||
|
@ -1712,7 +1712,7 @@ that were extrapolated from the standard curve were left unchanged.
|
|||
|
||||
In order to perform meta-analysis on all experimental data generate using the
|
||||
\gls{dms} system, we developed a program to curate and aggregate the raw
|
||||
datafiles into a \gls{sql} database (\cref{fig:meta_overview}).
|
||||
datafiles into a \gls{sql} database (\cref{sec:appendix_meta}).
|
||||
|
||||
The data files to be aggregated included Microsoft Excel files which held
|
||||
timeseries measurements for cell cultures (eg cell counts, viability, glucose,
|
||||
|
@ -1732,6 +1732,7 @@ This program included checks to ensure the integrity of source data (for
|
|||
example, flagging entries which had a reagent whose manufacturing date was after
|
||||
the date the experiment started, which signifies a human input error).
|
||||
|
||||
|
||||
\subsection{statistical analysis}\label{sec:statistics}
|
||||
|
||||
For 1-way \gls{anova} analysis with Tukey multiple comparisons test,
|
||||
|
@ -1740,11 +1741,8 @@ with the \inlinecode{t.test} method from the \inlinecode{ggpubr} library in R.
|
|||
For 2-way \gls{anova} analysis, the significance of main and interaction effects
|
||||
was determined using the car library in R.
|
||||
|
||||
% TODO not all of this stuff applied to my regressions
|
||||
For least-squares linear regression, statistical significance was evaluated the
|
||||
\inlinecode{lm} function in R. Stepwise regression models were obtained using
|
||||
the \inlinecode{stepAIC} function from the \inlinecode{MASS} package with
|
||||
forward and reverse stepping. All results with categorical variables are
|
||||
\inlinecode{lm} function in R. All results with categorical variables are
|
||||
reported relative to baseline reference. Each linear regression was assessed for
|
||||
validity using residual plots (to assess constant variance and independence
|
||||
assumptions), QQplots and Shapiro-Wilk normality test (to assess normality
|
||||
|
@ -1766,42 +1764,21 @@ context of pure error). Statistical significance was evaluated at $\upalpha$ =
|
|||
\label{fig:gating_strategy}
|
||||
\end{figure*}
|
||||
|
||||
% METHOD add flow cytometry
|
||||
|
||||
\begin{table}[!h] \centering
|
||||
\caption{\glspl{mab} used for flow cytometry}
|
||||
\label{tab:flow_mabs}
|
||||
\input{../tables/flow_mabs.tex}
|
||||
\end{table}
|
||||
|
||||
All \glspl{mab} used for flow cytometry are shown in \cref{tab:flow_mabs}. Other
|
||||
reagents for specialized assays such as degranulation are described in their
|
||||
respective sections. Cells were gated according to \cref{fig:gating_strategy}.
|
||||
|
||||
\section{results}
|
||||
|
||||
\subsection{DMSs can be fabricated in a controlled manner}
|
||||
|
||||
Two types of gelatin-based microcariers, \gls{cus} and \gls{cug}, were
|
||||
covalently conjugated with varying concentration of \gls{snb} and then coated
|
||||
with \gls{stp} and \glspl{mab} to make \glspl{dms}. Aside from slight
|
||||
differences in swelling ratio and crosslinking chemistry\cite{purcellmain} the
|
||||
properties of \gls{cus} and \gls{cug} were the same (\cref{tab:carrier_props}).
|
||||
We chose to continue with the \gls{cus}-based \glspl{dms}, which showed higher
|
||||
overall \gls{stp} binding compared to \gls{cug}-based \glspl{dms}
|
||||
(\cref{fig:cug_vs_cus}). We showed that by varying the concentration of
|
||||
\gls{snb}, we were able to precisely control the amount of attached biotin
|
||||
(\cref{fig:biotin_coating}), mass of attached \gls{stp}
|
||||
(\cref{fig:stp_coating}), and mass of attached \glspl{mab}
|
||||
(\cref{fig:mab_coating}). Furthermore, we showed that the microcarriers were
|
||||
evenly coated with \gls{stp} on the surface and throughout the interior as
|
||||
evidenced by the presence of biotin-binding sites occupied with
|
||||
\gls{stp}-\gls{fitc} on the microcarrier surfaces after the \gls{stp}-coating
|
||||
step (\cref{fig:stp_carrier_fitc}). Finally, we confirmed that biotinylated
|
||||
\glspl{mab} were bound to the \glspl{dms} by staining either \gls{stp} or
|
||||
\gls{stp} and \gls{mab}-coated carriers with \antim{\gls{igg}-\gls{fitc}} and
|
||||
imaging on a confocal microscope (\cref{fig:mab_carrier_fitc}). Taking this
|
||||
together, we noted that the maximal \gls{mab} binding capacity occurred near
|
||||
\SI{50}{\nmol} biotin input (which corresponded to
|
||||
\SI{2.5}{\nmol\per\mg\of{\dms}}) thus we used this in subsequent processes.
|
||||
|
||||
% TODO flip the rows of this figure (right now the text is backward)
|
||||
% FIGURE flip the rows of this figure (right now the text is backward)
|
||||
\begin{figure*}[ht!]
|
||||
\begingroup
|
||||
|
||||
|
@ -1829,15 +1806,28 @@ together, we noted that the maximal \gls{mab} binding capacity occurred near
|
|||
\label{fig:dms_coating}
|
||||
\end{figure*}
|
||||
|
||||
% TODO these caption titles suck
|
||||
% TODO combine this DOE figure into one interaction plot
|
||||
\begin{table}[!h] \centering
|
||||
\caption{Properties of the microcarriers used}
|
||||
\label{tab:carrier_props}
|
||||
\input{../tables/carrier_properties.tex}
|
||||
\end{table}
|
||||
|
||||
% TODO add chemical equation for which reactions I am describing here
|
||||
Two types of gelatin-based microcariers, \gls{cus} and \gls{cug}, were
|
||||
covalently conjugated with varying concentration of \gls{snb} and then coated
|
||||
with \gls{stp} and \glspl{mab} to make \glspl{dms}. Aside from slight
|
||||
differences in swelling ratio and crosslinking chemistry\cite{purcellmain} the
|
||||
properties of \gls{cus} and \gls{cug} were the same (\cref{tab:carrier_props}).
|
||||
We chose to continue with the \gls{cus}-based \glspl{dms}, which showed higher
|
||||
overall \gls{stp} binding compared to \gls{cug}-based \glspl{dms}
|
||||
(\cref{fig:cug_vs_cus}). We showed that by varying the concentration of
|
||||
\gls{snb}, we were able to precisely control the amount of attached biotin
|
||||
(\cref{fig:biotin_coating}), mass of attached \gls{stp}
|
||||
(\cref{fig:stp_coating}), and mass of attached \glspl{mab}
|
||||
(\cref{fig:mab_coating}). Furthermore, we showed that the microcarriers were
|
||||
evenly coated with \gls{stp} on the surface and throughout the interior as
|
||||
evidenced by the presence of biotin-binding sites occupied with \gls{fitcbt} on
|
||||
the microcarrier surfaces after the \gls{stp}-coating step
|
||||
(\cref{fig:stp_carrier_fitc}). Finally, we confirmed that biotinylated
|
||||
\glspl{mab} were bound to the \glspl{dms} by staining either \gls{stp}- or
|
||||
\gls{stp}/\gls{mab}-coated carriers with \antim{\gls{igg}-\gls{fitc}} and
|
||||
imaging on a confocal microscope (\cref{fig:mab_carrier_fitc}). Taking this
|
||||
together, we noted that the maximal \gls{mab} binding capacity occurred near
|
||||
\SI{50}{\nmol} biotin input (which corresponded to
|
||||
\SI{2.5}{\nmol\per\mg\of{\dms}}) thus we used this in subsequent processes.
|
||||
|
||||
We then asked how sensitive the \gls{dms} manufacturing process was to a variety
|
||||
of variables. In particular, we focused on the biotin-binding step, since it
|
||||
|
@ -1846,6 +1836,8 @@ appeared that the \gls{mab} binding was quadratically related to biotin binding
|
|||
critical to controlling the amount and \glspl{mab} and thus the amount of signal
|
||||
the T cells receive downstream.
|
||||
|
||||
% TODO these caption titles suck
|
||||
% TODO combine this DOE figure into one interaction plot
|
||||
\begin{figure*}[ht!]
|
||||
\begingroup
|
||||
|
||||
|
@ -1895,7 +1887,7 @@ We also observed that the reaction pH does not influence the amount of biotin
|
|||
attached (\cref{fig:dms_qc_ph}), which indicates that while higher pH might
|
||||
increase the number of deprotonated amines on the surface of the microcarrier,
|
||||
it also increases the number of \ce{OH-} groups which can spontaneously
|
||||
hydrolyze the \gls{snb} in solution.
|
||||
hydrolyze the \gls{snb} in solution (\cref{chem:snb_hydrolysis}).
|
||||
|
||||
Furthermore, we observed that washing the microcarriers after autoclaving
|
||||
increases the biotin binding rate (\cref{fig:dms_qc_washes}). While we did not
|
||||
|
@ -1907,20 +1899,20 @@ lightly-suspended peptides/protein fragments are also measured and therefore
|
|||
inflate the readout.
|
||||
|
||||
Lastly, we asked what the effect on reaction pH had on spontaneous degradation
|
||||
of \gls{snb} while in solution. If the \gls{snb} significantly degrades within
|
||||
minutes of preparation, then it is important to carefully control the timing
|
||||
between \gls{snb} solution preparation and addition to the microcarriers. We
|
||||
found that in the presence of \gls{di} water, \gls{snb} is extremely stable
|
||||
(\cref{fig:dms_snb_decay_curves}) where it decays rapidly in the presence of
|
||||
\gls{pbs} buffered to pH of 7.1. In fact, the \gls{di} water curve actually
|
||||
decreases slightly, possibly due to \gls{snb} absorbing to the plate surface.
|
||||
\gls{snb} is known to hydrolyze in the presence of \ce{OH-}, but the lack of
|
||||
hydrolysis in \gls{di} water can be explained by the fact that biotin itself is
|
||||
acidic, and thus the reaction is self-inhibitory in an unbuffered and neutral pH
|
||||
system. Because we dissolve our \gls{snb} in \gls{di} water prior to adding it
|
||||
to the microcarrier suspension (which itself is in \gls{pbs}) this result
|
||||
indicated that hydrolysis is not of concern when adding \gls{snb} within
|
||||
minutes.
|
||||
of \gls{snb} while in solution (\cref{chem:snb_hydrolysis}). If the \gls{snb}
|
||||
significantly degrades within minutes of preparation, then it is important to
|
||||
carefully control the timing between \gls{snb} solution preparation and addition
|
||||
to the microcarriers. We found that in the presence of \gls{di} water, \gls{snb}
|
||||
is extremely stable (\cref{fig:dms_snb_decay_curves}) where it decays rapidly in
|
||||
the presence of \gls{pbs} buffered to pH of 7.1. In fact, the \gls{di} water
|
||||
curve actually decreases slightly, possibly due to \gls{snb} absorbing to the
|
||||
plate surface. \gls{snb} is known to hydrolyze in the presence of \ce{OH-}, but
|
||||
the lack of hydrolysis in \gls{di} water can be explained by the fact that
|
||||
biotin itself is acidic, and thus the reaction is self-inhibitory in an
|
||||
unbuffered and neutral pH system. Because we dissolve our \gls{snb} in \gls{di}
|
||||
water prior to adding it to the microcarrier suspension (which itself is in
|
||||
\gls{pbs}) this result indicated that hydrolysis is not of concern when adding
|
||||
\gls{snb} within minutes.
|
||||
|
||||
\begin{figure*}[ht!]
|
||||
\begingroup
|
||||
|
@ -1946,47 +1938,53 @@ minutes.
|
|||
\label{fig:dms_kinetics}
|
||||
\end{figure*}
|
||||
|
||||
We also investigated the reaction kinetics of all three coating steps.
|
||||
\subsection{reaction kinetics for coating the DMSs}
|
||||
|
||||
To quantify the reaction kinetics of the biotin binding step, we reacted
|
||||
multiple batches of \SI{20}{\mg\per\ml} microcarriers in \gls{pbs} at \gls{rt}
|
||||
with \gls{snb} in parallel and sacrificially analyzed each at varying timepoints
|
||||
using the \gls{haba} assay. This was performed at two different concentrations.
|
||||
We observed that for either concentration, the reaction was over in
|
||||
We investigated the reaction kinetics of all three coating steps (accompanying
|
||||
MATLAB codes are provided in \cref{sec:appendix_binding}). To quantify the
|
||||
reaction kinetics of the biotin binding step, we reacted multiple batches of
|
||||
\SI{20}{\mg\per\ml} microcarriers in \gls{pbs} at \gls{rt} with \gls{snb} in
|
||||
parallel and sacrificially analyzed each at varying timepoints using the
|
||||
\gls{haba} assay. This was performed at two different concentrations. We
|
||||
observed that for either concentration, the reaction was over in
|
||||
\SIrange{20}{30}{\minute} (\cref{fig:dms_biotin_rxn_mass}). Furthermore, when
|
||||
put in terms of fraction of input \gls{snb}, we observed that the curves are
|
||||
almost identical (\cref{fig:dms_biotin_rxn_frac}). Given this, the reaction step
|
||||
for biotin attached was set to \SI{30}{\minute}\footnote{we actually used
|
||||
\SI{60}{\minute} for most of the runs as outlined in methods, which shouldn't
|
||||
make any difference except save for being excessive according to this result}.
|
||||
for biotin attached can be set to \SI{30}{\minute}\footnote{we actually used
|
||||
\SI{60}{\minute} as outlined in methods, which shouldn't make any difference
|
||||
except save for being excessive according to this result}.
|
||||
|
||||
% RESULT state how we calculated the number of stp/site
|
||||
Next, we quantified the amount of \gls{stp} reacted with the surface of the
|
||||
biotin-coated microcarriers. Different batches of biotin-coated \glspl{dms} were
|
||||
coated with \SI{40}{\ug\per\ml} \gls{stp} and sampled at intermediate timepoints
|
||||
using the \gls{bca} assay to indirectly quantify the amount of attached
|
||||
\gls{stp} mass. We found this reaction took approximately \SI{30}{\minute}
|
||||
(\cref{fig:dms_stp_per_time}). Assuming a quasi-steady-state paradigm, we used
|
||||
this experimental binding data to fit a continuous model for the \gls{stp}
|
||||
binding reaction. Using the diffusion rate of the \gls{stp}
|
||||
this experimental binding data to compute the geometric diffusivity of the
|
||||
microcarriers and fit a continuous model for the \gls{stp} binding reaction. We
|
||||
computed the number of `binding sites' using the maximum mass observed to bind
|
||||
to the \gls{dms}, which should describe the upper-bound for reaction time
|
||||
(\cref{fig:stp_coating}). Using the diffusion rate of the \gls{stp}
|
||||
(\SI{6.2e-7}{\cm\squared\per\second}), we then calculated the geometric
|
||||
diffusivity of the microcarriers to be 0.190 (see
|
||||
\cref{eqn:stp_diffusion_1,eqn:stp_diffusion_2}).
|
||||
|
||||
% RESULT state how I calculated the number of mab/surface area
|
||||
Using this effective diffusivity and the known diffusion coefficient of a
|
||||
\gls{mab} protein in water, we calculated predict the binding of \glspl{mab} per
|
||||
time onto the microcarriers (this obviously assumes that the effectively
|
||||
diffusivity is independent of the protein used, which should be reasonable given
|
||||
that the pores of the microcarriers are huge compared to the proteins, and we
|
||||
don't expect any significant reaction between the protein and the microcarrier
|
||||
surface save for the \gls{stp}-biotin binding reaction). According to this
|
||||
model, the \gls{mab} binding reaction should be complete within \SI{75}{\minute}
|
||||
under the conditions used for our protocol
|
||||
(\cref{fig:dms_mab_per_time})\footnote{We actually used \SI{60}{\minute} as
|
||||
describe in the method section as this model was not updated with new
|
||||
parameters until recently; however, we should point out that even at
|
||||
\SI{60}{\minute} the reaction appears to be >\SI{95}{\percent} complete}.
|
||||
Using this geometric diffusivity and the known diffusion coefficient of a
|
||||
\gls{mab} protein in water, we calculated the binding of \glspl{mab} per time
|
||||
onto the microcarriers (this obviously assumes that the effectively diffusivity
|
||||
is independent of the protein used, which should be reasonable given that the
|
||||
pores of the microcarriers are huge compared to the proteins, and we don't
|
||||
expect any significant reaction between the protein and the microcarrier surface
|
||||
save for the \gls{stp}-biotin binding reaction). Once again, we used the maximum
|
||||
number of \glspl{mab} observed to determine the number of `binding sites' for
|
||||
\glspl{mab} on the microcarriers, which should correspond to the upper-bound for
|
||||
the reaction time (\cref{fig:mab_coating}). According to this model, the
|
||||
\gls{mab} binding reaction should be complete within \SI{75}{\minute} under the
|
||||
conditions used for our protocol (\cref{fig:dms_mab_per_time})\footnote{We
|
||||
actually used \SI{60}{\minute} as describe in the method section as this model
|
||||
was not updated with new parameters until recently; however, we should point
|
||||
out that even at \SI{60}{\minute} the reaction appears to be
|
||||
>\SI{95}{\percent} complete}.
|
||||
|
||||
Finally, we calculated the number of wash steps needed to remove the reagents
|
||||
between each step, including the time for each wash which required the geometric
|
||||
|
@ -2024,9 +2022,11 @@ should not that the washing time for both the \gls{stp} and \gls{mab} coating
|
|||
steps were \SI{30}{\minute}, which is a significant margin of safety (albeit
|
||||
one that could be optimized).
|
||||
|
||||
MATLAB code and output for all the wash step calculations are given in
|
||||
\cref{sec:appendix_washing}.
|
||||
|
||||
\subsection{DMSs can efficiently expand T cells compared to beads}
|
||||
|
||||
% FIGURE make sure the day on these is correct
|
||||
\begin{figure*}[ht!]
|
||||
\begingroup
|
||||
|
||||
|
@ -2038,10 +2038,11 @@ one that could be optimized).
|
|||
\caption[T cells growing on \glspl{dms}]
|
||||
{Cells grow in tight clusters in and around functionalized \gls{dms}.
|
||||
\subcap{fig:dms_cells_phase}{Phase-contrast image of T cells growing on
|
||||
\glspl{dms} on day 7}
|
||||
\glspl{dms}}
|
||||
\subcap{fig:dms_cells_fluor}{Confocal images of T cells in varying z-planes
|
||||
growing on \glspl{dms} on day 9. \Glspl{dms} were stained using
|
||||
\gls{stppe} (red) and T cells were stained using \acd{45}-\gls{af647}.}
|
||||
Images are from day 7 of culture.
|
||||
}
|
||||
\label{fig:dms_cells}
|
||||
\end{figure*}
|
||||
|
@ -2202,28 +2203,26 @@ harvested after \SI{14}{\day}) (\cref{tab:inside_regression}).
|
|||
|
||||
After observing differences in expansion, we further hypothesized that the
|
||||
\gls{dms} cultures could lead to a different T cell phenotype. In particular, we
|
||||
were interested in the formation of naïve and memory T cells, as these represent
|
||||
a subset with higher replicative potential and therefore improved clinical
|
||||
prognosis\cite{Gattinoni2011, Wang2018}. We measured naïve and memory T cell
|
||||
frequency staining for CCR7 and CD62L (both of which are present on lower
|
||||
differentiated T cells such as naïve, central memory, and stem memory
|
||||
cells\cite{Gattinoni2012}). Using three donors, we noted again \glspl{dms}
|
||||
produced more T cells over a \SI{14}{\day} expansion than beads, with
|
||||
significant differences in number appearing as early after \SI{5}{\day}
|
||||
(\cref{fig:dms_exp_fold_change}). Furthermore, we noted that \glspl{dms}
|
||||
produced more memory/naïve cells after \SI{14}{\day} when compared to beads for
|
||||
all donors (\cref{fig:dms_exp_mem,fig:dms_exp_cd4}) showing that the \gls{dms}
|
||||
platform is able to selectively expand potent, early differentiation T cells.
|
||||
were interested in the formation of \glspl{tn}, \gls{tscm}, and \glspl{tcm} as
|
||||
these represent a subset with higher capacity to replicate and therefore
|
||||
improved clinical prognosis\cite{Gattinoni2011, Wang2018}. We measured the
|
||||
frequency of these subtypes by staining for CCR7 and CD62L. Using three donor
|
||||
lots, we noted again \glspl{dms} produced more T cells over a \SI{14}{\day}
|
||||
expansion than beads, with significant differences in number appearing as early
|
||||
after \SI{5}{\day} (\cref{fig:dms_exp_fold_change}). Furthermore, we noted that
|
||||
\glspl{dms} produced more memory/naïve cells after \SI{14}{\day} when compared
|
||||
to beads for all donors (\cref{fig:dms_exp_mem,fig:dms_exp_cd4}) showing that
|
||||
the \gls{dms} platform is able to selectively expand potent, early
|
||||
differentiation T cells.
|
||||
|
||||
Of additional interest was the preservation of the CD4+ compartment. In healthy
|
||||
donor samples (such as those used here), the typical CD4:CD8 ratio is 2:1. We
|
||||
noted that \glspl{dms} produced more CD4+ T cells than bead cultures as well as
|
||||
naïve/memory, showing that the \gls{dms} platform can selectively expand CD4 T
|
||||
cells to a greater degree than beads (Figure 2c). The trends held true when
|
||||
observing the CD4+ and CD8+ fractions of the naïve/memory subset (\ptmem{})
|
||||
(\cref{fig:dms_exp_mem4,fig:dms_exp_mem8}).
|
||||
cells to a greater degree than beads \cref{fig:dms_exp_cd4}. The trends held
|
||||
true when observing the CD4+ and CD8+ fractions of the naïve/memory subset
|
||||
(\ptmem{}) (\cref{fig:dms_exp_mem4,fig:dms_exp_mem8}).
|
||||
|
||||
% FIGURE this figure has weird proportions
|
||||
% FIGURE this figure was not produced with the same donors as the figure above,
|
||||
% which is really confusing
|
||||
\begin{figure*}[ht!]
|
||||
|
@ -2249,7 +2248,7 @@ experiments\footnote{these results were not always consistent, see the
|
|||
metaanalysis at the end of this aim for an in-depth quantification of this
|
||||
observation} that the fraction of \ptmem{} and \pth{} T cells was higher in
|
||||
the \gls{dms} groups compared to the bead groups (\cref{fig:dms_phenotype}).
|
||||
This result was seen for multiple donors. We should not that in the case of
|
||||
This result was seen for multiple donors. We should note that in the case of
|
||||
\pthp{}, the donors we used had an initial \pthp{} that was much higher (healthy
|
||||
donors generally have a CD4:CD8 ratio of 2:1), so the proper interpretation of
|
||||
this is that the \pthp{} decreases less over the culture period with the
|
||||
|
@ -2267,12 +2266,13 @@ technology.
|
|||
|
||||
After optimizing for naïve/memory and CD4 yield, we sought to determine if the
|
||||
\glspl{dms} were compatible with lentiviral transduction protocols used to
|
||||
generate \gls{car} T cells27,28. We added a \SI{24}{\hour} transduction step on
|
||||
day 1 of the \SI{14}{\day} expansion to insert an anti-CD19 \gls{car}29 and
|
||||
subsequently measured the surface expression of the \gls{car} on day 14
|
||||
\cref{fig:car_production_flow_pl,fig:car_production_endpoint_pl}. We noted that
|
||||
there was robust \gls{car} expression in over \SI{25}{\percent} of expanded T
|
||||
cells, and there was no observable difference in \gls{car} expression between
|
||||
generate \gls{car} T cells\cite{Tumaini2013, Lamers2014}. We added a
|
||||
\SI{24}{\hour} transduction step on day 1 of the \SI{14}{\day} expansion to
|
||||
insert an anti-CD19 \gls{car}\cite{Milone2009} and subsequently measured the
|
||||
surface expression of the \gls{car} on day 14
|
||||
(\cref{fig:car_production_flow_pl,fig:car_production_endpoint_pl}). We noted
|
||||
that there was robust \gls{car} expression in over \SI{25}{\percent} of expanded
|
||||
T cells, and there was no observable difference in \gls{car} expression between
|
||||
beads and \glspl{dms}.
|
||||
|
||||
We also verified the functionality of expanded \gls{car} T cells using a
|
||||
|
@ -2283,8 +2283,8 @@ appearance of CD107a on CD8+ T cells. CD107a is found on the inner-surface of
|
|||
cytotoxic granules and will emerge on the surface after cytotoxic T cells are
|
||||
activated and degranulate. Indeed, we observed degranulation in T cells expanded
|
||||
with both beads and \glspl{dms}, although not to an observably different degree
|
||||
\cref{fig:car_production_flow_degran,fig:car_production_endpoint_degran}. Taken
|
||||
together, these results indicated that the \glspl{dms} provide similar
|
||||
(\cref{fig:car_production_flow_degran,fig:car_production_endpoint_degran}).
|
||||
Taken together, these results indicated that the \glspl{dms} provide similar
|
||||
transduction efficiency compared to beads.
|
||||
|
||||
We also verified that expanded T cells were migratory using a chemotaxis assay
|
||||
|
@ -2298,6 +2298,7 @@ T cells expanded using beads, but this interaction effect was only weakly
|
|||
significant (p = 0.068). No such effect was seen for \gls{dms}-expanded T cells,
|
||||
showing that migration was likely independent of \gls{car} transduction.
|
||||
|
||||
% FIGURE break this up to give the text more flexibility
|
||||
\begin{figure*}[ht!]
|
||||
\begingroup
|
||||
|
||||
|
@ -2391,8 +2392,8 @@ we did not move the T cells to a larger bioreactor as they grew in contrast with
|
|||
our plate cultures. This means that the cells had higher growth area
|
||||
constraints, which may have nullified any advantage to the expansion that we
|
||||
seen elsewhere (\cref{fig:dms_exp_fold_change}). Furthermore, the higher growth
|
||||
area could mean higher signaling and higher differentiation rate to effector T
|
||||
cells, which was why the \ptmemp{} was so low compared to other data
|
||||
area could mean higher signaling and higher differentiation rate to
|
||||
\glspl{teff}, which was why the \ptmemp{} was so low compared to other data
|
||||
(\cref{fig:dms_phenotype_mem}).
|
||||
|
||||
\begin{figure*}[ht!]
|
||||
|
@ -2466,7 +2467,7 @@ Since the aim of the analysis was to perform causal inference, we determined 6
|
|||
possible treatment variables which we controlled when designing the experiments
|
||||
included in this dataset. Obviously the principle treatment parameter was
|
||||
‘activation method’ which represented the effect of activating T cells with
|
||||
either beads or our DMS method. We also included ‘bioreactor’ which was a
|
||||
either beads or our \gls{dms} method. We also included ‘bioreactor’ which was a
|
||||
categorical for growing the T cells in a Grex bioreactor vs polystyrene plates,
|
||||
‘feed criteria’ which represented the criteria used to feed the cells (using
|
||||
media color or a glucose meter), ‘IL2 Feed Conc’ as a continuous parameter for
|
||||
|
@ -2477,11 +2478,11 @@ size of our dataset, so the only two parameters for which causal relationships
|
|||
could be evaluated were ‘activation method’ and ‘bioreactor’. We should also
|
||||
note that these were not the only set of theoretical treatment parameters that
|
||||
we could have used. For example, media feed rate is an important process
|
||||
parameter, but this was dependent on the feeding criteria and the growth rate of
|
||||
the cells, which in turn is determined by activation method. Therefore, ‘media
|
||||
feed rate’ (or similar) is a ‘post-treatment parameter’ and would have violated
|
||||
the backdoor criteria and severely biased our estimates of the treatment
|
||||
parameters themselves.
|
||||
parameter, but in our experiments this was dependent on the feeding criteria and
|
||||
the growth rate of the cells, which in turn is determined by activation method.
|
||||
Therefore, ‘media feed rate’ (or similar) is a ‘post-treatment parameter’ and
|
||||
would have violated the backdoor criteria and severely biased our estimates of
|
||||
the treatment parameters themselves.
|
||||
|
||||
In addition to these treatment parameters, we also included covariates to
|
||||
improve the precision of our model. Among these were donor parameters including
|
||||
|
@ -2548,43 +2549,43 @@ We then included all covariates and unbalanced treatment parameters and
|
|||
performed linear regression again
|
||||
(\cref{tab:ci_controlled,fig:metaanalysis_fx}). We observe that after
|
||||
controlling for additional noise, the models explained much more variability
|
||||
($R^2$ between 0.76 and 0.87) and had relatively constant variance and small
|
||||
deviations for normality as per the assumptions of regression analysis {Figure
|
||||
X}. Furthermore, the coefficient for activation method in the case of fold
|
||||
change changed very little but still remained quite high (note the
|
||||
log-transformation) with \SI{143}{\percent} increase in fold change compared to
|
||||
beads. Furthermore, the coefficient for \ptmemp{} dropped to about
|
||||
\SI{2.7}{\percent} different and almost became non-significant at $\upalpha$ =
|
||||
0.05, and the \dpthp{} response increased to almost a \SI{9}{\percent} difference
|
||||
and became highly significant. Looking at the bioreactor treatment, we see that
|
||||
using the bioreactor in the case of fold change and \ptmemp{} is actually harmful
|
||||
to the response, while at the same time it seems to increase the \dpthp{}
|
||||
response. We should note that this parameter merely represents whether or not
|
||||
the choice was made experimentally to use a bioreactor or not; it does not
|
||||
indicate why the bioreactor helped or hurt a certain response. For example,
|
||||
using a Grex entails changing the cell surface and feeding strategy for the T
|
||||
cells, and any one of these ‘mediating variables’ might actually be the cause of
|
||||
the responses.
|
||||
($R^2$ between 0.76 and 0.87).
|
||||
% and had relatively constant variance and small
|
||||
% deviations for normality as per the assumptions of regression analysis {Figure
|
||||
% X}.
|
||||
Furthermore, the coefficient for activation method in the case of fold change
|
||||
changed very little but still remained quite high (note the log-transformation)
|
||||
with \SI{143}{\percent} increase in fold change compared to beads. Furthermore,
|
||||
the coefficient for \ptmemp{} dropped to a \SI{2.7}{\percent} increase and
|
||||
almost became non-significant at $\upalpha$ = 0.05, and the \dpthp{} response
|
||||
increased to almost a \SI{9}{\percent} increase and became highly significant.
|
||||
Looking at the bioreactor treatment, we see that using the bioreactor in the
|
||||
case of fold change and \ptmemp{} is actually harmful to the response, while at
|
||||
the same time it seems to increase the \dpthp{} response. We should note that
|
||||
this parameter merely represents whether or not the choice was made
|
||||
experimentally to use a bioreactor or not; it does not indicate why the
|
||||
bioreactor helped or hurt a certain response. For example, using a Grex entails
|
||||
changing the cell surface and feeding strategy for the T cells, and any one of
|
||||
these ‘mediating variables’ might actually be the cause of the responses.
|
||||
|
||||
\section{discussion}
|
||||
|
||||
% DISCUSSION this is fluffy
|
||||
We have developed a T cell expansion system that recapitulates key features of
|
||||
the in vivo lymph node microenvironment using DMSs functionalized with
|
||||
activating mAbs. This strategy provided superior expansion with higher number of
|
||||
naïve/memory and CD4+ T cells compared to state-of-the-art microbead technology
|
||||
(Figure 2). Other groups have used biomaterials approaches to mimic the \invivo{}
|
||||
microenvironment\cite{Cheung2018, Rio2018, Delalat2017, Lambert2017, Matic2013};
|
||||
however, to our knowledge this is the first system that specifically drives
|
||||
naïve/memory and CD4+ T cell formation in a scalable, potentially
|
||||
bioreactor-compatible manufacturing process.
|
||||
|
||||
% DISCUSSION assuage krish by showing that in the isotype control fig that IL2
|
||||
% doesn't activation T cells: https://www.jimmunol.org/content/jimmunol/191/12/5822.full.pdf
|
||||
We have developed a T cell expansion shows superior expansion with higher number
|
||||
of naïve/memory and CD4+ T cells compared to state-of-the-art microbead
|
||||
technology (\cref{fig:dms_exp}). Other groups have used biomaterials approaches
|
||||
to mimic the \invivo{} microenvironment\cite{Cheung2018, Rio2018, Delalat2017,
|
||||
Lambert2017, Matic2013}; however, to our knowledge this is the first system
|
||||
that specifically drives naïve/memory and CD4+ T cell formation in a scalable,
|
||||
potentially bioreactor-compatible manufacturing process. Given that the
|
||||
isotype-control \glspl{mab} does not lead to expansion and that \il{2} does not
|
||||
lead to expansion on its own (\cref{fig:dms_expansion_isotype}), we know that
|
||||
the expansion of the T cells shown here is due to the \acd{3} and \acd{28}
|
||||
\glspl{mab}\cite{Waysbort2013}.
|
||||
|
||||
Memory and naïve T cells have been shown to be important clinically. Compared to
|
||||
effectors, they have a higher proliferative capacity and are able to engraft for
|
||||
months; thus they are able to provide long-term immunity with smaller
|
||||
\glspl{teff}, they have a higher proliferative capacity and are able to engraft
|
||||
for months; thus they are able to provide long-term immunity with smaller
|
||||
doses\cite{Gattinoni2012, Joshi2008}. Indeed, less differentiated T cells have
|
||||
led to greater survival both in mouse tumor models and human
|
||||
patients\cite{Fraietta2018, Adachi2018, Rosenberg2011}. Furthermore, clinical
|
||||
|
|
Loading…
Reference in New Issue